Published in Clin Infect Dis on January 07, 2005
Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol (2006) 2.16
Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J Bacteriol (2006) 1.57
Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am (2009) 1.14
DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J Clin Microbiol (2005) 1.11
Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. Proc Natl Acad Sci U S A (2011) 1.09
Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus. PLoS One (2010) 1.06
A model for group B Streptococcus pilus type 1: the structure of a 35-kDa C-terminal fragment of the major pilin GBS80. J Mol Biol (2011) 1.06
Selection, recombination, and virulence gene diversity among group B streptococcal genotypes. J Bacteriol (2009) 1.01
A multi locus variable number of tandem repeat analysis (MLVA) scheme for Streptococcus agalactiae genotyping. BMC Microbiol (2011) 0.99
Association of Group B Streptococcus colonization and bovine exposure: a prospective cross-sectional cohort study. PLoS One (2010) 0.95
Mobile genetic elements provide evidence for a bovine origin of clonal complex 17 of Streptococcus agalactiae. Appl Environ Microbiol (2007) 0.92
The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus. Microbiology (2013) 0.89
Biofilm formation by Streptococcus agalactiae: influence of environmental conditions and implicated virulence factors. Front Cell Infect Microbiol (2015) 0.89
Molecular characterization of Streptococcus agalactiae isolated from bovine mastitis in Eastern China. PLoS One (2013) 0.88
Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev (2008) 0.84
Variation in the number of tandem repeats and profile of surface protein genes among invasive group B Streptococci correlates with patient age. J Clin Microbiol (2007) 0.84
Infection of human coronary artery endothelial cells by group B streptococcus contributes to dysregulation of apoptosis, hemostasis, and innate immune responses. Mediators Inflamm (2011) 0.82
Preliminary crystallographic study of the Streptococcus agalactiae sortases, sortase A and sortase C1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.79
Genome-wide analyses of small non-coding RNAs in streptococci. Front Genet (2015) 0.78
Proteomic biomarkers associated with Streptococcus agalactiae invasive genogroups. PLoS One (2013) 0.78
Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions. Acta Crystallogr D Biol Crystallogr (2013) 0.78
Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine (2009) 0.77
Group B Streptococcal Septic Arthritis of the Shoulder and Potential Association with Pelvic Examination and PAP Smear. Case Rep Orthop (2016) 0.75
Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis (2012) 2.96
Group B streptococcal infections in elderly adults. Clin Infect Dis (2005) 2.59
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics (2008) 2.45
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 2.20
Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis (2010) 2.09
Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States. Value Health (2009) 1.98
Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis (2004) 1.96
Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis (2011) 1.85
Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis (2004) 1.73
Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin Infect Dis (2001) 1.66
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis (2009) 1.64
Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics (2010) 1.59
Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol (2004) 1.53
Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis (2004) 1.48
Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol (2003) 1.42
Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J (2015) 1.39
An adolescent with fever, cough, & diffuse lymphadenopathy. Pediatr Infect Dis J (2007) 1.38
Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr (2005) 1.31
Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine (2003) 1.31
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2009) 1.22
Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J (2010) 1.20
Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics (2011) 1.15
Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J (2010) 1.15
Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis (2004) 1.14
Features of invasive staphylococcal disease in neonates. Pediatrics (2004) 1.13
Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis (2011) 1.10
Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J (2012) 1.09
Improved methods for typing nontypeable isolates of group B streptococci. Int J Med Microbiol (2002) 1.09
Determinants of co-colonization with group B streptococcus among heterosexual college couples. Epidemiology (2002) 1.08
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun (2002) 1.08
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis (2004) 1.06
Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis (2006) 1.06
DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol (2005) 1.03
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis (2003) 1.02
Antimicrobial stewardship in pediatrics: how every pediatrician can be a steward. JAMA Pediatr (2013) 1.01
Long-term outcomes of group B streptococcal meningitis. Pediatrics (2012) 1.01
Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J (2003) 1.01
Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children. J Clin Pharmacol (2003) 1.00
Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J (2015) 0.96
Pertussis immunization in a high-risk postpartum population. Vaccine (2009) 0.96
Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis (2012) 0.95
Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis (2002) 0.92
Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis (2013) 0.92
Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother (2013) 0.92
Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J (2011) 0.90
A report of three cases and review of intrauterine herpes simplex virus infection. Pediatr Infect Dis J (2011) 0.89
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis (2004) 0.88
A clinical analysis of shoulder and hip joint infections in children. J Pediatr Orthop (2010) 0.86
Altered gentamicin serum concentrations in obese pediatric patients. Pediatr Infect Dis J (2011) 0.86
The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis (2006) 0.86
Maternal immunization. Pediatr Infect Dis J (2007) 0.86
Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine (2012) 0.86
Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (2006) 0.85
Issues of antimicrobial resistance in group B streptococcus in the era of intrapartum antibiotic prophylaxis. Semin Pediatr Infect Dis (2006) 0.85
Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans. J Infect Dis (2006) 0.84
Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis (2002) 0.84
Thoracic actinomycosis in children: case report and review of the literature. Pediatr Infect Dis J (2008) 0.84
Bilateral lung abscesses in an adolescent. Semin Pediatr Infect Dis (2002) 0.83
Fluconazole prophylaxis in the neonatal intensive care unit. Pediatr Infect Dis J (2009) 0.82
An unusual cause of appendicitis in a child. Semin Pediatr Infect Dis (2006) 0.81
Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine (2010) 0.81
Infant pertussis: what to do next? Clin Infect Dis (2011) 0.81
What is a clinical pearl and what is its role in medical education? Med Teach (2008) 0.80
Value placed on formal training in education by pediatric department chairs and residency program directors. J Grad Med Educ (2011) 0.80
Brucellosis of the sternum and olecranon in an adolescent. Pediatr Infect Dis J (2007) 0.80
Once-daily gentamicin dosing in pediatric patients without cystic fibrosis. Pharmacotherapy (2010) 0.80
Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine (2007) 0.80
Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc (2004) 0.79
Advances in antifungal therapy. Pediatr Infect Dis J (2005) 0.79
Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J (2004) 0.78
The future of meningococcal vaccines. Pediatr Infect Dis J (2005) 0.78
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. Pediatr Infect Dis J (2004) 0.77
Modification of an evidence-based protocol for advanced appendicitis in children. J Surg Res (2013) 0.77
Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine (2009) 0.77
Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis (2006) 0.77
G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States. Emerg Infect Dis (2015) 0.77
Group B Streptococcal Colonization Among Pregnant Women in Delhi, India. Pediatr Infect Dis J (2016) 0.77